Anika Therapeutics, Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $8.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.8M | 31.7% |
| Other Financing | $1.3M | 15.2% |
| Working Capital | $885.5K | 10.1% |
| Net Cash Flow | $3.8M | 43.0% |